ROCKET PHARMACEUTICALS, INC.·4

Jun 26, 7:47 PM ET

Makker Gotham 4

4 · ROCKET PHARMACEUTICALS, INC. · Filed Jun 26, 2023

Insider Transaction Report

Form 4
Period: 2023-06-22
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-22$13.93/sh+2,872$40,0072,872 total
    Exercise: $21.56Exp: 2033-06-22Common Stock (2,872 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-06-22+25,85025,850 total
    Exercise: $21.56Exp: 2033-06-22Common Stock (25,850 underlying)
Footnotes (2)
  • [F1]This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024.
  • [F2]This option represents a right to purchase a total of 2,872 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024. This option was issued to the Reporting Person in lieu of director retainer fees of $40,000.

Documents

1 file
  • 4
    form4.xmlPrimary